Tag:
Echo Therapeutics
Latest Headlines
Latest Headlines
Targacept taps Stephen A. Hill to serve as president and CEO
Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad) from your shop to Alison Bryant ( email | Twitter ) and we will feature it...
Echo gets $20M in financing to market glucose monitor
Echo Therapeutics is angling to get regulatory approval for its wireless, non-invasive glucose monitor, and the company now has a $20 million line of credit to speed the process, thanks to Platinum-Montaur Life Sciences.
Echo's trandsdermal tech gets positive results, TV time
Echo Therapeutics is reporting positive clinical trial results for its transdermal glucose monitor, and its CEO will get a chance to discuss them on national TV.
Echo Therapeutics reports $16.7M loss after Prelude delay
Philadelphia-based Echo Therapeutics took a $16.7 million loss in 2011, a year in which the company had planned to launch its needle-free, transdermal drug delivery platform, the Prelude SkinPrep System.
Echo Therapeutics video shows pain-free skin prep
When last we left Echo Therapeutics in February , the Franklin, MA-based company was speeding up the launch of its Prelude SkinPrep System for transdermal drug delivery after receiving word from the
Echo Therapeutics: Prelude delivery device launch on track
Franklin, MA-based Echo Therapeutics is speeding up the launch of its non-invasive drug delivery system and announced plans to list on a national exchange. The company, along with its partners
